EP 1037894 A1 20000927 - PHARMACEUTICALS
Title (en)
PHARMACEUTICALS
Title (de)
ARZNEIMITTEL
Title (fr)
PRODUITS PHARMACEUTIQUES
Publication
Application
Priority
- EP 9807764 W 19981201
- GB 9725933 A 19971205
Abstract (en)
[origin: WO9929697A1] Novel oxazino[3,2-a]indole-10-carboxamide derivatives having 5-HT4 receptor antagonist activity and useful in the treatment of gastrointestinal disorders, cardiovascular disorders and CNS disorders, including irritable bowel syndrome.
IPC 1-7
IPC 8 full level
A61K 31/5365 (2006.01); A61P 1/00 (2006.01); A61P 1/08 (2006.01); A61P 1/14 (2006.01); A61P 9/00 (2006.01); A61P 9/06 (2006.01); A61P 25/06 (2006.01); A61P 25/22 (2006.01); A61P 43/00 (2006.01); C07D 498/04 (2006.01)
CPC (source: EP)
A61P 1/00 (2017.12); A61P 1/08 (2017.12); A61P 1/14 (2017.12); A61P 9/00 (2017.12); A61P 9/06 (2017.12); A61P 25/06 (2017.12); A61P 25/22 (2017.12); A61P 43/00 (2017.12); C07D 498/04 (2013.01)
Citation (search report)
See references of WO 9929697A1
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9929697 A1 19990617; CA 2312844 A1 19990617; EP 1037894 A1 20000927; GB 9725933 D0 19980204; JP 2001525415 A 20011211
DOCDB simple family (application)
EP 9807764 W 19981201; CA 2312844 A 19981201; EP 98965209 A 19981201; GB 9725933 A 19971205; JP 2000524290 A 19981201